Ryunosuke Machida

Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial

Jun Sato, Miyako Satouchi, Shoichi Itoh et al. · The Lancet Oncology · 2020 · 203 citations

Oncology, Metastatic Thymic Carcinoma, Metronomic Therapy +5

A randomized controlled phase III trial comparing two chemotherapy regimen and chemoradiotherapy regimen as neoadjuvant treatment for locally advanced esophageal cancer, JCOG1109 NExT study.

Ken Kato, Yoshinori Ito, Hiroyuki Daiko et al. · Journal of Clinical Oncology · 2022 · 191 citations

Surgical Oncology, Esophageal Cancer, Cancer Management +19

Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2–Expressing Advanced or Recurrent Uterine Carcinosarcoma (NCCH1615): The STATICE Trial

Tadaaki Nishikawa, Kosei Hasegawa, Koji Matsumoto et al. · Journal of Clinical Oncology · 2023 · 116 citations · Full text

TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma

Kenji Fujimoto, Hideyuki Arita, Kaishi Satomi et al. · Acta Neuropathologica · 2021 · 103 citations

Neuro-oncology, Somatic Variant, Medicine +9

Impact of postoperative complications on survival outcomes in patients with gastric cancer: exploratory analysis of a randomized controlled JCOG1001 trial

Masanori Tokunaga, Yukinori Kurokawa, Ryunosuke Machida et al. · Gastric Cancer · 2020 · 84 citations · Full text

Gastrointestinal Oncology, Medicine, Jcog1001 Trial +10